Prostate cancer Board decisions

The Board granted service connection for prostate cancer but dismissed the claims for an increased rating for left ear hearing loss and service connection for right ear hearing loss due to a pre-decisional duty-to-assist error.

The Board remands the claims for a higher rating for respiratory conditions and service connection for kidney, prostate, bladder cancer, and obstructive sleep apnea due to outstanding medical records and inadequate VA opinions.

The proposed rating reduction for prostate cancer, which is currently rated as 100 percent disabling, was dismissed because the appeal was filed prematurely.

The Board remands the claim for a new VA examination to provide an opinion on whether the Veteran's prostate cancer is related to service, including exposure to chemicals in association with his military duties.

The Board dismissed the veteran's claims for increased ratings and TDIU due to various conditions, as the issues were remanded under the modernized appeal system.

The Board remands the claims for service connection for diabetes mellitus, prostate cancer, a skin condition, and a bilateral foot condition due to insufficient evidence in the file.

The Board granted an effective date of March 22, 2019, for the awards of service connection for arteriosclerotic heart disease (CAD), prostate cancer, and hypertension.

The Board remands the claim for service connection for prostate cancer to correct a duty to assist error in satisfying the regulatory duty to provide the Veteran with notice of his right to a pre-decisional hearing.

The Board denied service connection for a low back disability, to include lumbar spondylosis; residuals of prostate carcinoma (claimed as prostate cancer); and increased ratings for degenerative changes with meniscal tear of the right knee and sinusitis. The Veteran's combined disability evaluation was also denied.

The Board remands the claims for service connection for prostate cancer and bladder condition to allow for readjudication based on new evidence.

The Board granted an effective date of July 31, 2020, for the award of service connection for anterior trunk scar and an initial 70 percent disability rating for major depressive disorder.

The Board granted service connection for coronary artery disease, prostate cancer, and bladder cancer due to presumed exposure to herbicide agents during the Veteran's service in the Korean DMZ.

The claims for service connection for diabetes, prostate cancer, and hypertension are remanded for further development regarding potential herbicide exposure outside of Vietnam.

The Board granted service connection for neoplasm of the colon, including polyps and reopened a claim for prostate cancer. The claims for incisional hernia repair and psychiatric disability were remanded.

The Board granted service connection for diabetes mellitus type II due to Agent Orange exposure and granted a total disability rating based on individual unemployability due to the Veteran's service-connected disabilities, while remanding an increased rating claim for residuals of prostate cancer (voiding dysfunction).

The Board denied higher ratings for prostate cancer, ED, and hypertension but granted a 10 percent initial rating for hypertension. Service connection was denied for lung cancer, bladder cancer, hyperglycemia, and COPD.

The Board remands the claims for service connection for left shoulder pain, right shoulder pain, low back pain, prostate cancer, erectile dysfunction, and high blood pressure to correct pre-decisional duty to assist errors.

The Board denied service connection for various disabilities, including lumbar spine degenerative disc disease, right and left lower extremity disabilities, nausea, hypertension, loss of smell, loss of taste, kidney disorder, prostatic hypertrophy, prostate cancer, post cranial nodes, boils on the shoulders, armpits, groin, and neck, gynecomastia, and an ear tumor. The claims were denied as there was no evidence linking these conditions to service or toxic exposure at Camp Lejeune.

The Board granted a greater 60 percent rating for the Veteran's residuals of prostate cancer status post radical prostatectomy and a total disability rating based on individual unemployability (TDIU).

The Board denied ratings in excess of 60 percent for prostate cancer, 30 percent for PTSD, and noncompensable ratings for hypertension and chronic kidney disease. However, TDIU was granted due to the Veteran's service-connected disabilities.